Assignee profile:

VERSI GROUP, LLC

City:

Gladstone, New Jersey

Country:

United States

Published Applications:

10

Last publication date:

2020-04-23

Patent Grants:

10

Last grant date:

2022-02-15

Top Inventors for applications by VERSI GROUP, LLC

These are the the leading inventors for applications assigned to VERSI GROUP, LLC:

Recent patent applications by VERSI GROUP, LLC

VERSI GROUP, LLC based in Gladstone, US has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:

#1 | 2020-04-23 ✅ Patent 11,246,865 granted on 2022-02-15
US20200121674A1
Human necessities

Opioid for use to reduce and/or treat drug addiction

#2 | 2019-02-07 ✅ Patent 10,973,815 granted on 2021-04-13
US20190038620A1
Human necessities

Delta opioid agonist mu opioid antagonist compositions and methods for treating Parkinsons disease

#3 | 2017-10-12 ✅ Patent 10,071,093 granted on 2018-09-11
US20170290823A1
Human necessities

Method of treating Parkinson's Disease with a diarylmethylpiperazine compounds exhibiting delta opioid receptor agonist activity

#4 | 2015-01-15 ✅ Patent 9,296,707 granted on 2016-03-29
US20150018372A1
Chemistry; metallurgy

Delta opioid receptor agonist compounds

#5 | 2014-10-23 ✅ Patent 9,701,645 granted on 2017-07-11
US20140315922A1
Chemistry; metallurgy

Method of treating Parkinson's disease with a diarylmethylpiperazine compounds exhibiting delta opioid receptor agonist activity

#6 | 2014-01-30 ✅ Patent 8,865,721 granted on 2014-10-21
US20140031367A1
Chemistry; metallurgy

Delta opioid receptor agonist compounds

#7 | 2013-07-02 ✅ Patent 8,476,280 granted on 2013-07-02
US10434004
-

Compositions and methods for combating lower urinary tract dysfunctions with delta opioid receptor agonists

#8 | 2013-02-28 ✅ Patent 8,575,169 granted on 2013-11-05
US20130053326A9
Chemistry; metallurgy

Method of treating sexual dysfunctions with delta opioid receptor agonist compounds

#9 | 2012-08-30 ✅ Patent 8,551,998 granted on 2013-10-08
US20120220601A1
Chemistry; metallurgy

Delta opioid receptor agonist compounds

#10 | 2007-03-22 ✅ Patent 8,642,599 granted on 2014-02-04
US20070066625A1
Human necessities

Method of treating Parkinson's Disease with diarylmethylpiperazine compounds exhibiting delta receptor agonist activity

Also check out VERSI GROUP, LLC's (Gladstone, United States) applicant profile with 6 patent applications submitted.

AssigneeID:

53466 ⎘